Struggling With Weight in Menopause? What to Know About Weight-Loss Injections
By Dr Daniel Gordon • 07, Jan 2026
Are Weight-Loss Injections Helpful During Menopause?
Weight gain during perimenopause and menopause is one of the most common and distressing concerns women raise in clinic. Many describe doing everything they’ve always been advised to do; eating well, exercising regularly, and looking after their health, yet finding that their weight still creeps up regardless.
This can feel deeply frustrating and often leads women to blame themselves. In reality, these changes are driven by shifts in hormones, metabolism, sleep, and body composition, not a lack of effort.
Weight-loss injections, including GLP-1 receptor agonists, are now part of the conversation. They are often described as life-changing, but also surrounded by confusion and mixed messaging.
In this article, I’ll explain how these medications may fit into care during perimenopause and menopause, who they may help, and why they should always sit within a broader, personalised healthcare plan that supports long-term health, not just weight loss.
What are GLP-1 receptor agonists, and how do they work?
GLP-1 receptor agonists are a group of medications originally developed to treat type 2 diabetes and now widely used for weight management. They include medications such as Ozempic, Wegovy and Mounjaro, which I’ve covered in more detail in my article Ozempic, Wegovy and Mounjaro: A Complete Guide to GLP-1 Weight Loss Medications.
These medications work by mimicking a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). This hormone plays an important role in regulating appetite, blood sugar levels, and digestion.
By acting on appetite centres in the brain and slowing stomach emptying, GLP-1 medications help people feel fuller for longer, reduce hunger, and decrease constant thoughts about food. For many women, particularly during perimenopause and menopause, this reduction in “food noise” can be one of the most noticeable effects.
Why GLP-1 medications appeal during perimenopause and menopause
During perimenopause and menopause, hormonal changes can significantly affect how the body regulates weight. Falling oestrogen levels influence appetite, insulin sensitivity, and fat distribution, often leading to increased abdominal fat.
At the same time, many women experience disrupted sleep, mood changes, increased stress, and reduced energy. Metabolism may slow, and muscle mass naturally declines with age, making weight gain more likely even when lifestyle habits have not changed.
In this context, GLP-1 weight-loss medications can feel particularly appealing.
From a health perspective, GLP-1 medications work best and most safely when used as part of a broader approach that supports nutrition, muscle strength, hormonal health, and emotional wellbeing.
Weight-loss injections should be part of a real healthcare plan
One of my strongest concerns is seeing medications such as Ozempic, Wegovy and Mounjaro used in isolation, without appropriate support or follow-up.
Perimenopause and menopause are complex hormonal transitions that affect far more than weight. They influence bone and muscle health, cardiovascular risk, mental wellbeing, and overall quality of life.
Any decision to use weight-loss injections should sit within a personalised healthcare plan that considers:
Hormonal symptoms and whether menopause hormone replacement therapy is appropriate
Nutritional intake and the risk of deficiencies
Muscle mass and bone health
Mental health, stress, and relationship with food
Existing medical conditions and current medications
When weight-loss injections are used without a broader healthcare context, the risk of rapid weight loss, muscle loss, fatigue, hair shedding, and declining nutritional status increases.
Building healthy lifestyle habits during perimenopause and menopause
Even when appetite is reduced by weight-loss injections, nutrition remains essential during perimenopause and menopause, when the body is already undergoing significant hormonal and metabolic change.
Adequate protein intake is particularly important at this stage of life to help preserve muscle mass, which naturally declines during menopause. Resistance and weight-bearing exercise play a key role in maintaining muscle strength, supporting metabolism, and protecting bone density.
Eating regular, balanced meals, staying well hydrated, and ensuring sufficient dietary fibre can help manage common side effects of GLP-1 medications, such as constipation. Sleep quality, stress management, and gentle daily movement also have a powerful influence on weight regulation, energy levels, and overall wellbeing during menopause.
Weight-loss injections should be used to support healthy lifestyle habits in menopause, not replace them.
Common symptoms to watch for during treatment
Women using weight-loss injections during perimenopause and menopause may be more vulnerable to certain side effects. The most common include fatigue, constipation, nausea, and hair shedding, particularly if weight loss occurs too quickly or nutrition is inadequate.
If symptoms are persistent, severe, or begin to affect quality of life, this is an important signal to reassess dosage, the pace of weight loss, or whether the medication remains the right option for you.
No one should feel they need to push through feeling unwell in the pursuit of weight loss.
Practical advice for women in perimenopause and menopause
Weight-loss injections can be a helpful tool for some women, but they are not a magic solution and not a requirement for good health.
If you are considering weight-loss injections, keep the focus on long-term health:
Aim for slow, sustainable weight loss rather than rapid results
Prioritise nutrition, muscle strength, and mental wellbeing
Seek care from clinicians who understand menopause, not just prescribing protocols
Most importantly, remember that menopause is a significant physiological transition. Supporting your body through it with compassion, evidence-based care, and realistic expectations is far more important than chasing a number on the scales.
For a more detailed overview of perimenopause and menopause, including symptoms and treatment options, you may find my article Perimenopause and Menopause: How to Recognise the Symptoms and When to Seek Help helpful.
Disclaimer
This blog post provides general information only. It is not intended to provide instruction and you should not rely on this information to determine a diagnosis, prognosis or course of treatment. It should not be used in place of a professional consultation with a doctor.
The medical information is the personal opinion of the stated author(s). It is based on available evidence or, where no published evidence is available, on current medical opinion and practice.
Every effort is taken to ensure that the information contained in this website is accurate and complete. However, accuracy cannot be guaranteed – rapid advances in medicine may cause information contained here to become outdated, invalid or subject to debate.
The author(s) is/are not responsible for the results of your decisions resulting from the use of the information, including, but not limited to, your choosing to seek or not to seek professional medical care, or from choosing or not choosing specific treatment based on the information.
You should not disregard the advice of your physician or other qualified healthcare provider because of any information you read on this website. If you have any health care questions, please consult a relevant medical practitioner.
